Breadcrumb

What’s new at The Institute?

Advancing Equity in Research

For Black History Month, patient partners, community actors, academics, and clinicians gathered at The Institute to address racism

New study reveals key mechanism behind natural resistance to tuberculosis

Researchers identify a unique immune response in the lungs that may help prevent tuberculosis infection...

Driving innovation in rare disease research: The Institute and RARE.Qc

New funding from Génome Québec will strengthen rare disease data infrastructure, accelerating research and discoveries

New global guideline on candidiasis features expertise from The Institute

Dr. Don Vinh, the only Canadian primary author, joins over 100 experts from 35 countries in this landmark effort

Engineered IL-2 molecule shows promise in treating autoimmune disease

Researchers from The Institute, in collaboration with Sanofi, develop a novel therapy to enhance immune regulation in...

D2R awards over $6 million to support Core Platforms

Three platforms at The Institute will benefit from new funding for innovation and sustainability

New discovery could help protect against influenza

Preclinical trial uncovers how beta-glucan, found in all fungi, can ‘reprogram’ immune cells to prevent lung inflammation

Ensuring everyone can fully participate in research and healthcare

The MUHC and The Institute’s accessibility plan is commended by the Office des personnes handicapées...

Franco Carnevale: a lifelong commitment to respecting and elevating children’s voices

Championing children's rights in medical care, Franco Carnevale combines nursing, psychology, and ethics.

New discovery sheds light on male infertility

Researchers at The Institute reveal how a lipid signaling pathway regulates sperm function, paving the way for innovative diagnostics

Learn more about the RI-MUHC